Advancing Biologic Drug Products With Integrated Development And Analytical Services At CPHI Worldwide

CPHI Worldwide in Milan is one of the leading global events for the pharmaceutical industry, bringing together pharma companies, CDMOs, and service providers to drive solutions for late-stage development and commercialization.

As drug products move through development, priorities shift from feasibility to robustness, manufacturability, analytical confidence, and regulatory readiness. At this stage, programs benefit from specialized partners who can combine predictive tools, formulation expertise, analytical development, GMP-compliant testing, and troubleshooting support.

This is where Coriolis Pharma’s integrated service portfolio supports the development, characterization, and release of complex biologic drug substances and drug products.